ROCA Test Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.28M

  • Investors
  • 1

ROCA Test General Information

Description

Developer of molecular diagnostics technology designed to provide commercial development of novel tests for the early detection of cancer. The company's technology is engaged in the discovery and verification of biomarkers for the early detection and screening of ovarian cancer, enabling people to get diagnosed, on the basis of expert measurements and dynamic changes over time through serum-based biomarkers, before cancer is clinically diagnosed.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Saint John's Innovation Centre
  • Cowley Road
  • Cambridge CB4 0WS
  • England, United Kingdom
+44 020
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Saint John's Innovation Centre
  • Cowley Road
  • Cambridge CB4 0WS
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ROCA Test Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 27-Sep-2022 $2.28M Completed Generating Revenue
5. Later Stage VC 14-Jul-2022 Completed Generating Revenue
4. Later Stage VC 07-May-2015 Completed Clinical Trials - General
3. Grant 08-Jan-2014 Completed Clinical Trials - General
2. Early Stage VC 24-May-2011 $1.68M $1.68M Completed Clinical Trials - General
1. University Spin-Out 22-Sep-2010 Completed Startup
To view ROCA Test’s complete valuation and funding history, request access »

ROCA Test Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C Ordinary
B Ordinary
A Ordinary
A Ordinary
Ordinary 56,250 $0.001212 $19.4 $19.4 1x $19.4 5.1%
Ordinary 8,929 $0.001212 $16.97 $16.97 1x $16.97 0.81%
To view ROCA Test’s complete cap table history, request access »

ROCA Test Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of molecular diagnostics technology designed to provide commercial development of novel tests for the early de
Diagnostic Equipment
Cambridge, United Kingdom
5 As of 2023

Boston, MA
 

Schlieren, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ROCA Test Competitors (30)

One of ROCA Test’s 30 competitors is Foundation Medicine, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Formerly VC-backed Boston, MA
ProteoMediX Formerly VC-backed Schlieren, Switzerland
AcuamarkDx Venture Capital-Backed New York, NY
Asuragen Formerly VC-backed Austin, TX
Epigenomics Formerly VC-backed Heidelberg, Germany
You’re viewing 5 of 30 competitors. Get the full list »

ROCA Test Patents

ROCA Test Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021209752-A1 Storing and processing longitudinal data sets Inactive 17-Apr-2020

ROCA Test Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ROCA Test Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Albion Crown VCT Venture Capital Minority
AlbionVC Venture Capital Minority
Cancer Research Technology Venture Capital Minority
Creandum Venture Capital Minority
Horizon 2020 Government
You’re viewing 5 of 9 investors. Get the full list »

ROCA Test FAQs

  • When was ROCA Test founded?

    ROCA Test was founded in 2010.

  • Where is ROCA Test headquartered?

    ROCA Test is headquartered in Cambridge, United Kingdom.

  • What is the size of ROCA Test?

    ROCA Test has 5 total employees.

  • What industry is ROCA Test in?

    ROCA Test’s primary industry is Diagnostic Equipment.

  • Is ROCA Test a private or public company?

    ROCA Test is a Private company.

  • What is the current valuation of ROCA Test?

    The current valuation of ROCA Test is .

  • What is ROCA Test’s current revenue?

    The current revenue for ROCA Test is .

  • How much funding has ROCA Test raised over time?

    ROCA Test has raised $16.3M.

  • Who are ROCA Test’s investors?

    Albion Crown VCT, AlbionVC, Cancer Research Technology, Creandum, and Horizon 2020 are 5 of 9 investors who have invested in ROCA Test.

  • Who are ROCA Test’s competitors?

    Foundation Medicine, ProteoMediX, AcuamarkDx, Asuragen, and Epigenomics are some of the 30 competitors of ROCA Test.

  • When was ROCA Test acquired?

    ROCA Test was acquired on 27-Sep-2022.

  • Who acquired ROCA Test?

    ROCA Test was acquired by GENinCode.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process